BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND B2M, P61769, 567, ENSG00000166710
197 results:

  • 1. The prognosis of patients with primary pulmonary mucosa-associated lymphoid tissue lymphoma: Treated with surgery or chemotherapy?
    Ning Y; He H; Li Q; Zhao D; Xie D
    Eur J Cardiothorac Surg; 2024 Mar; 65(3):. PubMed ID: 38400749
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic value of the peripheral blood lymphocyte/monocyte ratio combined with
    Wu W; Zhao L; Wang Y; Chen P; Yuan X; Miao L; Zhu Y; Mao J; Cai Z; Ji Y; Wang L; Jia T
    Curr Probl Cancer; 2024 Feb; 48():101066. PubMed ID: 38364336
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies.
    Chen X; Tan B; Xing H; Zhao X; Ping Y; Zhang Z; Huang J; Shi X; Zhang N; Lin B; Cao W; Li X; Zhang X; Li L; Jiang Z; Zhang M; Li W; Liu M; Du B; Zhang Y
    Cancer Immunol Immunother; 2024 Jan; 73(1):13. PubMed ID: 38231412
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Primary bone diffuse large B-cell lymphoma (PB-DLBCL): a distinct extranodal lymphoma of germinal centre origin, with a common EZB-like mutational profile and good prognosis.
    Ivanova VS; Davies J; Menter T; Wild D; Müller A; Krasniqi F; Stenner F; Papachristofilou A; Dirnhofer S; Tzankov A
    Histopathology; 2024 Feb; 84(3):525-538. PubMed ID: 37965677
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.
    Russler-Germain DA; Krysiak K; Ramirez C; Mosior M; Watkins MP; Gomez F; Skidmore ZL; Trani L; Gao F; Geyer S; Cashen AF; Mehta-Shah N; Kahl BS; Bartlett NL; Alderuccio JP; Lossos IS; Ondrejka SL; Hsi ED; Martin P; Leonard JP; Griffith M; Griffith OL; Fehniger TA
    Blood Adv; 2023 Sep; 7(18):5524-5539. PubMed ID: 37493986
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification and validation of the optimal reference genes for standardizing the gene expression profiling diagnostic panel of Ph-like B-lineage acute lymphoblastic leukemia.
    Gupta DG; Varma N; Abdulkadir SA; Singh P; Sachdeva MUS; Naseem S; Siddiqui MR; Bose P; Binota J; Malhotra P; Khadwal A; Varma S
    Clin Exp Med; 2023 Dec; 23(8):4539-4551. PubMed ID: 37470909
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Efficacy and safety of PD-1 monoclonal antibody plus rituximab in relapsed/refractory diffuse large B cell lymphoma patients.
    Qin Y; He X; Chen X; Xie Z; Yang J; Yang S; Liu P; Zhou S; Zhang C; Gui L; Shi Y
    Eur J Haematol; 2023 Sep; 111(3):356-364. PubMed ID: 37294015
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Mutational Spectrum and Prognosis Analysis of Young Patients with Diffuse Large B-Cell lymphoma Based on Next-Generation Sequencing].
    Lyu LY; Nie YL; Renaguli A; Qi XL; Muhebaier A; Zhai SS; An L; Mao M; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):403-410. PubMed ID: 37096512
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
    Shen R; Fu D; Dong L; Zhang MC; Shi Q; Shi ZY; Cheng S; Wang L; Xu PP; Zhao WL
    Signal Transduct Target Ther; 2023 Apr; 8(1):145. PubMed ID: 37032379
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pharmacologic targeting of Nedd8-activating enzyme reinvigorates T-cell responses in lymphoid neoplasia.
    Wang X; Chen C; Vuong D; Rodriguez-Rodriguez S; Lam V; Roleder C; Wang JH; Kambhampati S; Berger A; Pennock N; Torka P; Hernandez-Ilizaliturri F; Siddiqi T; Wang L; Xia Z; Danilov AV
    Leukemia; 2023 Jun; 37(6):1324-1335. PubMed ID: 37031300
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Unraveling the genetics of transformed splenic marginal zone lymphoma.
    Grau M; López C; Navarro A; Frigola G; Nadeu F; Clot G; Bastidas-Mora G; Alcoceba M; Baptista MJ; Blanes M; Colomer D; Costa D; Domingo-Domènech E; Enjuanes A; Escoda L; Forcada P; Giné E; Lopez-Guerra M; Ramón O; Rivas-Delgado A; Vicente Folch L; Wotherspoon A; Climent F; Campo E; López-Guillermo A; Matutes E; Beà S
    Blood Adv; 2023 Jul; 7(14):3695-3709. PubMed ID: 36995085
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical Trials Portfolio and Regulatory History of Idelalisib in Indolent Non-Hodgkin lymphoma: A Systematic Review and Meta-analysis.
    Banerjee T; Kim MS; Haslam A; Prasad V
    JAMA Intern Med; 2023 May; 183(5):435-441. PubMed ID: 36939665
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Primary Mediastinal B-Cell lymphoma in Children and Young Adults.
    Forlenza CJ; Chadburn A; Giulino-Roth L
    J Natl Compr Canc Netw; 2023 Mar; 21(3):323-330. PubMed ID: 36898366
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Molecular Evolution of Classic Hodgkin lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells.
    Maura F; Ziccheddu B; Xiang JZ; Bhinder B; Rosiene J; Abascal F; Maclachlan KH; Eng KW; Uppal M; He F; Zhang W; Gao Q; Yellapantula VD; Trujillo-Alonso V; Park SI; Oberley MJ; Ruckdeschel E; Lim MS; Wertheim GB; Barth MJ; Horton TM; Derkach A; Kovach AE; Forlenza CJ; Zhang Y; Landgren O; Moskowitz CH; Cesarman E; Imielinski M; Elemento O; Roshal M; Giulino-Roth L
    Blood Cancer Discov; 2023 May; 4(3):208-227. PubMed ID: 36723991
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Evaluation of serum interleukin 2 receptor and beta-2-microglobulin as prognostic factors for canine lymphoma: A pilot study.
    Im JH; Park SM; An JH; Kim TH; Chae HK; Oh YI; Seo KW; Youn HY
    Vet Comp Oncol; 2023 Jun; 21(2):184-190. PubMed ID: 36635848
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Primary cutaneous blastic marginal zone lymphoma: A comprehensive clinical, light microscopic, phenotypic and cytogenetic appraisal.
    Magro CM; Kalomeris T; Roberts A
    Ann Diagn Pathol; 2023 Apr; 63():152101. PubMed ID: 36634549
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Low T-cell proportion in the tumor microenvironment is associated with immune escape and poor survival in diffuse large B-cell lymphoma.
    Song JY; Nwangwu M; He TF; Zhang W; Meawad H; Bedell V; Murata-Collins J; Skrabek P; Nasr MR; Scott D; Godfrey J; Lee P; Chan WC; Weisenburger DD; Perry AM; Herrera AF
    Haematologica; 2023 Aug; 108(8):2167-2177. PubMed ID: 36632739
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.
    Parry EM; Leshchiner I; Guièze R; Johnson C; Tausch E; Parikh SA; Lemvigh C; Broséus J; Hergalant S; Messer C; Utro F; Levovitz C; Rhrissorrakrai K; Li L; Rosebrock D; Yin S; Deng S; Slowik K; Jacobs R; Huang T; Li S; Fell G; Redd R; Lin Z; Knisbacher BA; Livitz D; Schneider C; Ruthen N; Elagina L; Taylor-Weiner A; Persaud B; Martinez A; Fernandes SM; Purroy N; Anandappa AJ; Ma J; Hess J; Rassenti LZ; Kipps TJ; Jain N; Wierda W; Cymbalista F; Feugier P; Kay NE; Livak KJ; Danysh BP; Stewart C; Neuberg D; Davids MS; Brown JR; Parida L; Stilgenbauer S; Getz G; Wu CJ
    Nat Med; 2023 Jan; 29(1):158-169. PubMed ID: 36624313
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Mortality Among Pediatric Patients With Acute Lymphoblastic Leukemia in Sweden From 1988 to 2017.
    Björk-Eriksson T; Boström M; Bryngelsson IL; Lähteenmäki PM; Jarfelt M; Kalm M; Olsson DS
    JAMA Netw Open; 2022 Nov; 5(11):e2243857. PubMed ID: 36441552
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Risk Factors for and Outcomes of Follicular lymphoma Histological Transformation at First Progression in the GALLIUM Study.
    Casulo C; Herold M; Hiddemann W; Iyengar S; Marcus RE; Seymour JF; Launonen A; Knapp A; Nielsen TG; Mir F
    Clin Lymphoma Myeloma Leuk; 2023 Jan; 23(1):40-48. PubMed ID: 36379880
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.